No Data
No Data
Kanghong Pharmaceutical's Unit Gets Nod to Market Raw Ingredient for Tofacitinib Citrate
Kanghong Pharmaceutical Group's (SHE:002773) unit, Sichuan Hongyuan Pharmaceutical, received approval from China's National Medical Products Administration to produce and market the raw drug
Chengdu Kanghong Pharmaceutical Group (002773.SZ): approved for launch of levonorgestrel fumarate.
On July 5th, Gelonhui reported that Chengdu Kanghong Pharmaceutical Group (002773.SZ) announced that its wholly-owned subsidiary, Sichuan Hongyuan Pharmaceutical Co., Ltd. (referred to as 'Sichuan Hongyuan'), received the 'Chemical Raw Material Drug Market Application Approval Notice' (Notice No.: 2024YS00666) issued by the National Medical Products Administration today, approving the production of this product. Fumaric acid levonolol is a potassium ion competitive blocker. The original research product was first approved for domestic marketing in December 2019, with indications for reflux esophagitis.
Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Chengdu Kanghong Pharmaceutical Group (SZSE:002773) has had a great run on the share market with its stock up by a significant 22% over the last three months. Given that the market rewards strong fi
Kanghong Pharmaceutical's Unit Gets Nod to Market Conbercept Eye Injection in Myanmar
Kanghong Pharmaceutical Group's (SHE:002773) unit, Chengdu Kanghong Biotechnology, is allowed to market an eye injection in Myanmar after it received a drug registration certificate from the country's
Chengdu Kanghong Pharmaceutical Group (002773.SZ) has received the Drug Registration Certificate from the Food and Drug Administration of the Ministry of Health of Myanmar.
On June 18th, Gelonhui announced that Chengdu Kanghong Biotechnology Co., Ltd., a wholly-owned subsidiary of Chengdu Kanghong Pharmaceutical Group, and China International Medical and Health Co., Ltd. (the exclusive registered dealer in the Republic of the Union of Myanmar, hereinafter referred to as Myanmar) have recently received supervision and administration from the Food and Drug Administration of the Ministry of Health of the Government of the Republic of the Union of Myanmar regarding drugs and food.
Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Shareholders Have Endured a 30% Loss From Investing in the Stock Five Years Ago
It is a pleasure to report that the Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) is up 31% in the last quarter. But over the last half decade, the stock has not performed well. In
No Data